Production (Stage)
Camp4 Therapeutics Corporation
CAMP
$2.00
-$0.005-0.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.37% | 1.52% | -7.75% | -0.50% | 4.14% |
| Total Depreciation and Amortization | 0.72% | 0.00% | -2.79% | -1.38% | 0.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.40% | -38.09% | 63.12% | -1.75% | 18.63% |
| Change in Net Operating Assets | -1,352.86% | -77.36% | 189.25% | -255.93% | -32.37% |
| Cash from Operations | -26.56% | -16.46% | 21.13% | -10.30% | 5.43% |
| Capital Expenditure | -6.08% | -- | 100.00% | -493.33% | 93.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.08% | -- | 100.00% | -493.33% | 93.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 28.44% | -2.93% | -0.49% | 0.00% | 13.56% |
| Issuance of Common Stock | -- | 246,458.06% | 3,000.00% | -50.00% | -98.84% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1,390.57% | 30.26% | -- | -- |
| Cash from Financing | -100.21% | 19,027.98% | 23.87% | -150.99% | -220.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -123.92% | 710.29% | 21.79% | -13.44% | 6.03% |